These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35248875)

  • 1. Mindfulness-Oriented Recovery Enhancement reduces opioid craving, pain, and negative affect among chronic pain patients on long-term opioid therapy: An analysis of within- and between-person state effects.
    Parisi A; Hanley AW; Garland EL
    Behav Res Ther; 2022 May; 152():104066. PubMed ID: 35248875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial.
    Garland EL; Hanley AW; Kline A; Cooperman NA
    Drug Alcohol Depend; 2019 Oct; 203():61-65. PubMed ID: 31404850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mindfulness-Oriented Recovery Enhancement vs Supportive Group Therapy for Co-occurring Opioid Misuse and Chronic Pain in Primary Care: A Randomized Clinical Trial.
    Garland EL; Hanley AW; Nakamura Y; Barrett JW; Baker AK; Reese SE; Riquino MR; Froeliger B; Donaldson GW
    JAMA Intern Med; 2022 Apr; 182(4):407-417. PubMed ID: 35226053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mindfulness-Oriented Recovery Enhancement for Veterans and Military Personnel on Long-Term Opioid Therapy for Chronic Pain: A Randomized Clinical Trial.
    Garland EL; Nakamura Y; Bryan CJ; Hanley AW; Parisi A; Froeliger B; Marchand WR; Donaldson GW
    Am J Psychiatry; 2024 Feb; 181(2):125-134. PubMed ID: 38196335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary measurement and mindfulness-based modulation of prescription opioid cue-reactivity.
    Hanley AW; Garland EL
    Drug Alcohol Depend; 2020 Dec; 217():108351. PubMed ID: 33070057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mindfulness-oriented recovery enhancement reduces opioid misuse risk via analgesic and positive psychological mechanisms: A randomized controlled trial.
    Garland EL; Hanley AW; Riquino MR; Reese SE; Baker AK; Salas K; Yack BP; Bedford CE; Bryan MA; Atchley R; Nakamura Y; Froeliger B; Howard MO
    J Consult Clin Psychol; 2019 Oct; 87(10):927-940. PubMed ID: 31556669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain, hedonic regulation, and opioid misuse: Modulation of momentary experience by Mindfulness-Oriented Recovery Enhancement in opioid-treated chronic pain patients.
    Garland EL; Bryan CJ; Finan PH; Thomas EA; Priddy SE; Riquino MR; Howard MO
    Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S65-S72. PubMed ID: 28363322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dispositional mindfulness and prescription opioid misuse among chronic pain patients: Craving and attention to positive information as mediating mechanisms.
    Priddy SE; Hanley AW; Riquino MR; Platt KA; Baker AK; Garland EL
    Drug Alcohol Depend; 2018 Jul; 188():86-93. PubMed ID: 29754031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mindfulness-Oriented Recovery Enhancement remediates anhedonia in chronic opioid use by enhancing neurophysiological responses during savoring of natural rewards.
    Garland EL; Fix ST; Hudak JP; Bernat EM; Nakamura Y; Hanley AW; Donaldson GW; Marchand WR; Froeliger B
    Psychol Med; 2023 Apr; 53(5):2085-2094. PubMed ID: 37310337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoom-Based Mindfulness-Oriented Recovery Enhancement Plus Just-in-Time Mindfulness Practice Triggered by Wearable Sensors for Opioid Craving and Chronic Pain.
    Garland EL; Gullapalli BT; Prince KC; Hanley AW; Sanyer M; Tuomenoksa M; Rahman T
    Mindfulness (N Y); 2023 May; ():1-17. PubMed ID: 37362184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Mindfulness-Oriented Recovery Enhancement on reward responsiveness and opioid cue-reactivity.
    Garland EL; Froeliger B; Howard MO
    Psychopharmacology (Berl); 2014 Aug; 231(16):3229-38. PubMed ID: 24595503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Mindfulness-Oriented Recovery Enhancement Versus Social Support on Negative Affective Interference During Inhibitory Control Among Opioid-Treated Chronic Pain Patients: A Pilot Mechanistic Study.
    Garland EL; Bryan MA; Priddy SE; Riquino MR; Froeliger B; Howard MO
    Ann Behav Med; 2019 Aug; 53(10):865-876. PubMed ID: 30668631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mindfulness-Oriented Recovery Enhancement remediates hedonic dysregulation in opioid users: Neural and affective evidence of target engagement.
    Garland EL; Atchley RM; Hanley AW; Zubieta JK; Froeliger B
    Sci Adv; 2019 Oct; 5(10):eaax1569. PubMed ID: 31663023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autonomic and affective mediators of the relationship between mindfulness and opioid craving among chronic pain patients.
    Baker AK; Garland EL
    Exp Clin Psychopharmacol; 2019 Feb; 27(1):55-63. PubMed ID: 30265061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial.
    Garland EL; Manusov EG; Froeliger B; Kelly A; Williams JM; Howard MO
    J Consult Clin Psychol; 2014 Jun; 82(3):448-459. PubMed ID: 24491075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, health, and well-being.
    Cooperman NA; Hanley AW; Kline A; Garland EL
    J Subst Abuse Treat; 2021 Aug; 127():108468. PubMed ID: 34134880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To be aware, or to accept, that is the question: Differential roles of awareness of automaticity and pain acceptance in opioid misuse.
    Parisi A; Zgierska AE; Burzinski CA; Lennon RP; Jamison RN; Nakamura Y; Barrett B; Edwards RR; Garland EL
    Drug Alcohol Depend; 2023 Jun; 247():109890. PubMed ID: 37167796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Day-to-day hedonic and calming effects of opioids, opioid craving, and opioid misuse among patients with chronic pain prescribed long-term opioid therapy.
    Frimerman L; Verner M; Sirois A; Scott K; Bruneau A; Perez J; Shir Y; Martel MO
    Pain; 2021 Aug; 162(8):2214-2224. PubMed ID: 33729213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emotional distress and pain catastrophizing predict cue-elicited opioid craving among chronic pain patients on long-term opioid therapy.
    Parisi A; Landicho HL; Hudak J; Leknes S; Froeliger B; Garland EL
    Drug Alcohol Depend; 2022 Apr; 233():109361. PubMed ID: 35278786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid attentional bias and cue-elicited craving predict future risk of prescription opioid misuse among chronic pain patients.
    Garland EL; Howard MO
    Drug Alcohol Depend; 2014 Nov; 144():283-7. PubMed ID: 25282309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.